Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by James N Ingle

101-150 of 374 results

View this query on the Wikidata Query Service
Increased HER2 with U.S. Food and Drug Administration-approved antibody

scientific article published on 01 January 1999
Extended adjuvant endocrine therapy in breast cancer: current status and future directions

scientific article published on October 2008
Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody

scientific article published on February 2012
Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus

scientific article
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

scientific article
Using the gene ontology to scan multilevel gene sets for associations in genome wide association studies

scientific article published on 7 December 2011
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer

scientific article
Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization

scientific article
Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue.

scientific article
Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol

scientific article published on 01 December 1994
Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials

scientific article published on 31 August 2011
Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial

article
A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches

scientific article
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status

scientific article published on 20 July 2009
Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.

scientific article published in May 2005
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.

scientific article published on 15 March 2006
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.

scientific article published on 10 March 2008
Aromatase immunoreactivity is increased in mammographically dense regions of the breast

scientific article
Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain

scientific article published on 15 May 2008
TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression

scientific article published on 21 March 2013
Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer

scientific article published on 01 June 1986
Pericardial effusion in women with breast cancer

scientific article published on 01 July 1987
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma

scientific article published on 01 March 1999
Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance).

scientific article
Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy

scientific article published on 10 October 2016
A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy.

scientific article published on 01 August 1982
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women

scientific article published on 09 January 2011
SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen

scientific article published on 3 October 2011
Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313).

scientific article published in February 2007
Aromatase Inhibitor-Associated Bone Fractures: A Case-Cohort GWAS and Functional Genomics

scientific article published on August 22, 2014
Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer

scientific article published on 16 September 2009
p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905).

scientific article
Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells

scientific article published on March 19, 2012
Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancer

scientific article published on 01 April 1982
A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma

scientific article
Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms

scientific article published on July 2008
Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.

scientific article published on 2 April 2007
Estrogen replacement therapy withdrawal and regression of metastatic breast cancer

scientific article published on 01 January 1995
Endoxifen's molecular mechanisms of action are concentration dependent and different than that of other anti-estrogens

scientific article
Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors

scientific article published on 01 October 2008
Identification of a novel percent mammographic density locus at 12q24.

scientific article
Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation

scientific article published on 11 February 2016
A randomized Phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma

scientific article published on July 15, 1997
Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome

scientific article
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study

article
A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic

scientific article published in July 1991
Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma

scientific article
Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial

scientific article
Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.

scientific article
Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole

scientific article

Paulina is supported by:

About Paulina

Help